Skip to main content
NCBI home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1970 Apr 25;102(8):835–838.

The Effect of Isoproterenol on Airway Obstruction in Cystic Fibrosis

Elizabeth A Featherby, Tzong-Ruey Weng, Henry Levison
PMCID: PMC1946679  PMID: 5445046

Abstract

The effect of isoproterenol inhalations was studied on 95 occasions in 47 patients with cystic fibrosis.

Spirometric and airway resistance measurements showed small but statistically significant changes in the MMEF, MBC and airway resistance, although there was considerable variation from patient to patient. Over-inflation of the lungs, as indicated by a high thoracic gas volume, was not significantly decreased by the administration of the drug.

It is suggested that before using isoproterenol routinely as a treatment for cystic fibrosis, response to this drug should be measured in each individual patient.

Full text

PDF
835

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beier F. R., Renzetti A. D., Jr, Mitchell M., Watanabe S. Pulmonary pathophysiology in cystic fibrosis. Am Rev Respir Dis. 1966 Sep;94(3):430–440. doi: 10.1164/arrd.1966.94.3.430. [DOI] [PubMed] [Google Scholar]
  2. DUBOIS A. B., BOTELHO S. Y., COMROE J. H., Jr A new method for measuring airway resistance in man using a body plethysmograph: values in normal subjects and in patients with respiratory disease. J Clin Invest. 1956 Mar;35(3):327–335. doi: 10.1172/JCI103282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Featherby E. A., Weng T. R., Levison H. Measurement of response to isoprenaline in asthmatic children. Arch Dis Child. 1969 Jun;44(235):382–386. doi: 10.1136/adc.44.235.382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. GANDEVIA B., ANDERSON C. The effect of a bronchodilator aerosol on ventilatory capacity in fibrocystic disease of the pancreas. Arch Dis Child. 1959 Dec;34:511–515. doi: 10.1136/adc.34.178.511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Kamel M., Weng T. R., Featherby E. A., Jackman W. S., Levison H. Relationship of mechanics of ventilation to lung volumes in children and young adults. Scand J Respir Dis. 1969;50(2):125–134. [PubMed] [Google Scholar]
  6. MATTHEWS L. W., DOERSHUK C. F., WISE M., EDDY G., NUDELMAN H., SPECTOR S. A THERAPEUTIC REGIMEN FOR PATIENTS WITH CYSTIC FIBROSIS. J Pediatr. 1964 Oct;65:558–575. doi: 10.1016/s0022-3476(64)80290-0. [DOI] [PubMed] [Google Scholar]
  7. Mellins R. B., Levin O. R., Ingram R. H., Jr, Fishman A. P. Obstructive disease of the airways in cystic fibrosis. Pediatrics. 1968 Mar;41(3):560–573. [PubMed] [Google Scholar]
  8. Oppenheimer E. A., Rigatto M., Fletcher C. M. Airways obstruction before and after isoprenaline, histamine, and presnisolone in patients with chronic obstructive bronchitis. Lancet. 1968 Mar 16;1(7542):552–557. doi: 10.1016/s0140-6736(68)92829-8. [DOI] [PubMed] [Google Scholar]
  9. WEST J. R., LEVIN S. M., DI SANT'AGNESE P. A. Pulmonary function in cystic fibrosis of the pancreas. Pediatrics. 1954 Feb;13(2):155–164. [PubMed] [Google Scholar]
  10. Weng T. R., Levison H. Standards of pulmonary function in children. Am Rev Respir Dis. 1969 Jun;99(6):879–894. doi: 10.1164/arrd.1969.99.6.879. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES